Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
392 result(s) found, displaying 101 to 125
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 3 November 2022
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), 9 February 2023.
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in June 2022
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in November 2022
-
Scheduling decisions (final)Public notice of final decisions to amend (or not amend) the Poisons Standard - ACMS, June 2022
-
Meeting statementsMeeting statement from meeting 9 of the MDCWG.
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), December 2022.
-
Scheduling decisions (final)Public notice of final decisions to amend (or not amend) the Poisons Standard - ACMS, ACCS and joint ACMS-ACCS, June 2022
-
Meeting statementsCommunique from the 2nd meeting of the Women's Health Products Working Group (WHPWG), 20 October 2022
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in November 2021
-
Meeting statementsMeeting statement from meeting 8 of the MDCWG.
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in June 2021
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsCommunique from the meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), October 2022.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - November 2021 ACMS/ACCS meetings
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2022 ACMS/ACCS meetings
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsThe TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
-
Scheduling decisions (final)Public notice of final decision to amend (or not to amend) the Poisons Standard, ACMS #37, ACCS #33, Joint ACMS-ACCS #30
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the Poisons Standard, Joint ACMS-ACCS #29 in November 2021.
-
Meeting statementsAdvisory Committee on Vaccines, meeting 34, held 6 July 2022